Hair stem cell transplantation clinic in Jakarta The applicant, Hair Science Institute B.V. (Initial Capital B.V.) has developed a patented Hair Stemcell Transplantation technique with certain advantages for the customer compared to conventional hair transplantation techniques. HST is already in use in four HASCI clinics in Europe. In Asia loss of hair is seen as a (cultural) problem because it lowers social status in that region. This creates a commercial potential for a HST Clinique. Currently, many potential customers travel to Europe for a hair transplantation.The joint venture between HASCI and the local partner PT Akurat Intan Madya, active as supplier and developer of medical equipment and diagnostic tests, will set up a hair transplantation clinic in Jakarta which will serve the Indonesian and regional market. The clinic will operate under high European quality standards regarding (post) patient treatment, hygiene, dermatology and diagnostic test. The joint venture will create 45 jobs for dermatologists and nurses.Corporate Social Responsibility (CSR)The project will apply the same high social, medical and quality standards as HASCI is applying in Europe. The joint venture will be ISO 9001:2008 certified. Also, "Good Clinical Practices" will apply. This exceeds the common practice in Indonesia.The project will adhere to a sound environmental policy including conservation of energy, waste treatment/collection.Employees will be offered good (secondary) labour conditions including fair wages, payment of overtime, vacation days, free lunches and corporate health and accident insurance and a HIV/AIDS policy.The clinic will refrain from involvement in any form of corruption or bribery and will not allow the use of child or forced labour.Impact•	Employment and working conditionsThe joint venture ensures good working conditions and will apply the same high social, ethical, medical and quality level as currently applied by HASCI in the Netherlands. The clinic will also adhere to the principles of Good Clinical Practice.Fringe benefits are satisfactory including payments of at least 25% above minimum wage, full-time contracts, a bonus scheme for good performance, overtime payment, free lunch, corporate health and accident insurance.•	Innovation / Transfer of knowledgeHair Stemcell Transplantation technology is new for the country. It is an improved surgical treatment for loss of hair.•	Chain effectsThe joint venture will source different product locally from 12 suppliers including medical utensils, medicines, diagnostic tests, legal services and advertising services.The market segment targets the 5% upper income class.The joint venture will treat five persons per year who suffer from burn wounds.•	Impact on the sectorThe joint venture will may create further impact by collaborating with hospitals. However, the HST treatment will be exclusively available in the clinic itself and will not be made available to outsiders for the time being. This may be reconsidered in future when the success of this concept in Asia has been proven.•	EnvironmentWaste of the clinic will be disposed of properly. Medical disposals will be offered to a medical waste collector. The joint venture will adhere to a strict environmental policy.•	Position of womenThe joint venture will create 29 jobs for women which is 64% of the work force. The goal is to execute 328 hair stem cell transplantations per year for Indonesian and other clients from South-East Asia per year.